Immunome, Inc. · NASDAQ:IMNM
Bienaime Jean Jacques bought 10,500 and sold 10,500 Immunome, Inc. shares (Form 4)
Traded Jun 5, 2026 · Filed Jun 9, 2026
On Jun 5, 2026, Bienaime Jean Jacques (Director) bought 10,500 and sold 10,500 Immunome, Inc. shares, leaving 43,415 shares. Filed Jun 9, 2026 (Form 4).
- Bought
- 10,500 shares (US$204K at an average US$19.45)
- Sold
- 10,500 shares (US$204K at an average US$19.41)
- Holding after
- 43,415 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Common Stock | Sale | 500 | US$19.44 | 42,915 | Direct |
| Jun 5, 2026 | Common Stock | Sale | 10,000 | US$19.41 | 32,915 | Direct |
| Jun 5, 2026 | Common Stock | Buy | 6,000 | US$19.48 | 38,915 | Direct |
| Jun 5, 2026 | Common Stock | Buy | 3,500 | US$19.46 | 42,415 | Direct |
| Jun 5, 2026 | Common Stock | Buy | 1,000 | US$19.27 | 43,415 | Direct |
Source
Related
- Immunome, Inc.
- Bienaime Jean Jacques
- Immunome, Inc. shareholders
- Form 4 · Bienaime Jean Jacques · May 19, 2026
- Form 4 · Higgins Jack · Sep 15, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Form 4 · Barchas Isaac · Aug 12, 2026
- Form 4 · Barchas Isaac · Aug 10, 2026